Recent insider trading activity from Stark Charles William, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2024 | Emmaus Life Sciences, Inc. | $EMMA | Stark Charles William | CSO & EVP Clinical Development | A | Options | 200000 | $0.15 | 200,000.0000 | 0 | 9999.99% | 0.00% |